What to expect from SVRA’s earnings report this quarter?

Savara Inc (SVRA)’s stock is trading at $2.91 at the moment marking a rise of 7.96% from the last session close. As of this writing, shares are priced at -37.98% less than their 52-week high of $4.70, and 54.23% over their 52-week low of $1.89. Based on the past 30-day period, the stock price is -0.86% below the high and +28.67% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, SVRA’s SMA-200 is $2.85.

SVRA’s price to book ratio for the most recent quarter was 4.18, resulting in an 3.44 price to cash per share for the period.

How does Savara Inc (SVRA) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 8 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.50 in simple terms.

Savara Inc (SVRA): Earnings History

If we examine Savara Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.14, beating the consensus of -$0.12. In other words, it beat the consensus by -$0.02, resulting in a -16.67% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.14 in contrast with the Outlook of -$0.12. That was a difference of -$0.02 and a surprise of -16.67%.

Savara Inc (SVRA): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 4 different analysts, who are expecting earnings to fall in between the range of -0.10 and -0.12 with an average Earnings Estimate of -0.12 which is in contrast with the last year earnings estimate of -0.11 and also replicates -9.09% growth rate year over year.

Savara Inc (NASDAQ: SVRA) Ownership Details

I will give a breakdown of the key shareholders in Savara Inc (SVRA). Recent figures show that the company’s insiders hold 5.38% of shares. A total of 185 institutional investors hold shares in the company, making 101.32% of its stock and 107.08% of its float.

Mar 31, 2025, it was reported that the Company’s largest institutional holder is NEA Management Company, LLC holding total of 24.47 shares that make 14.16% of the company’s total number of shares and are currently priced at 72.56 million.

The securities firm Bain Capital Life Sciences Investors, LLC holds 17.6 shares of SVRA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 10.18%, and the holding percentage of shares is valued at 52.19 million.

An overview of Savara Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Savara Inc (SVRA) traded 967,010 shares per day, with a moving average of $2.59 and price change of +0.56. With the moving average of $2.39 and a price change of +0.49, about 1,093,130 shares changed hands on average over the past 50 days. Finally, SVRA’s 100-day average volume is 1,301,472 shares, alongside a moving average of $2.65 and a price change of +0.08.

Hot this week

Is it possible to buy Osisko Development Corp(ODV) shares at a good price now?

While Osisko Development Corp has underperformed by -2.16%, investors...

Examining Organigram Global Inc (OGI) stock is warranted

Within its last year performance, OGI rose by 7.45%,...

Compass Pathways Plc ADR (CMPS)’s results reveal risk

While Compass Pathways Plc ADR has underperformed by -8.11%,...

Was there any good news for SNDL Inc (SNDL) stock in the last session?

While SNDL Inc has underperformed by -0.37%, investors are...

It would be worthwhile to take a closer look at PTL Ltd (PTLE)

While PTL Ltd has underperformed by -2.31%, investors are...

Topics

Is it possible to buy Osisko Development Corp(ODV) shares at a good price now?

While Osisko Development Corp has underperformed by -2.16%, investors...

Examining Organigram Global Inc (OGI) stock is warranted

Within its last year performance, OGI rose by 7.45%,...

Compass Pathways Plc ADR (CMPS)’s results reveal risk

While Compass Pathways Plc ADR has underperformed by -8.11%,...

Was there any good news for SNDL Inc (SNDL) stock in the last session?

While SNDL Inc has underperformed by -0.37%, investors are...

It would be worthwhile to take a closer look at PTL Ltd (PTLE)

While PTL Ltd has underperformed by -2.31%, investors are...

The INmune Bio Inc (INMB) had a good session last reading, didn’t it?

While INmune Bio Inc has underperformed by -2.87%, investors...

How should investors view Canaan Inc ADR (CAN)?

While Canaan Inc ADR has underperformed by -2.01%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.